drug
as of 2026-07-01AUT00206
at a glance
small molecule
Pre-approval / investigational in the US
Developed by Autifony Therapeutics Limited
2 trials in the graph
Synthesized from structured facts only — each point cited above.
Mechanism & identity
Modality
small molecule
Indications
Investigational (via trials)
Trials
2
Safety, Tolerability and Pharmacokinetics of AUT00206 in Patients With Schizophrenia, and Also Explores the Effects of AUT00206 on Relevant Central Biomarkers.
NCT03164876Phase 1Completed
Safety, Blood Levels and Effects of AUT00206
NCT02589262Phase 1Completed
Facts & assertions
0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
developer
trial
indication
indication
indication